» Articles » PMID: 10328549

Gliomatosis Cerebri with Secondary Glioblastoma Formation: Report of Two Cases

Overview
Date 1999 May 18
PMID 10328549
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The clinicopathological features of two cases of gliomatosis cerebri associated with secondary glioblastoma formation are reported. In both cases, glial cells were diffusely distributed in the supra- and infratentorial regions and underlying brain structures were preserved from the onset. In spite of such diffuse distribution of neoplastic glial cells, similar to that observed in low-grade astrocytoma, in both cases the tumor underwent complete remission after radiotherapy. However, the tumor recurred as a localized glioblastoma in both cases, 37 months (case 1) and 7 months (case 2) after the radiotherapy. In both cases, recurrence was accompanied by prominent dissemination of CSF. The recurrent tumors were radiation resistant, and the patients' conditions deteriorated rapidly after recurrence. The present two cases demonstrated that gliomatosis cerebri, classified among brain tumors of unknown origin by the World Health Organization, may transform into highly proliferative circumscribed tumors, in spite of their good response to radiotherapy. Examination of pathological features and their correlation with MRI findings may allow us to better understand the response to radiotherapy and the process of recurrence.

Citing Articles

Differential transformation capacity of neuro-glial progenitors during development.

Munoz D, Singh S, Tung T, Agnihotri S, Nagy A, Guha A Proc Natl Acad Sci U S A. 2013; 110(35):14378-83.

PMID: 23942126 PMC: 3761617. DOI: 10.1073/pnas.1303504110.


Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.

Inoue T, Kumabe T, Kanamori M, Sonoda Y, Watanabe M, Tominaga T Neurosurg Rev. 2011; 34(2):197-208.

PMID: 21301914 DOI: 10.1007/s10143-010-0306-1.


Evaluation of molecular genetic alterations associated with tumor progression in a case of gliomatosis cerebri.

Braeuninger S, Schneider-Stock R, Kirches E, Powers J, Korones D, Mawrin C J Neurooncol. 2006; 82(1):23-7.

PMID: 16955219 DOI: 10.1007/s11060-006-9245-7.


Assessment of tumor cell invasion factors in gliomatosis cerebri.

Mawrin C, Schneider T, Firsching R, Wiedemann F, Dietzmann K, Bornemann A J Neurooncol. 2005; 73(2):109-15.

PMID: 15981099 DOI: 10.1007/s11060-004-4206-5.


Alterations of cell cycle regulators in gliomatosis cerebri.

Mawrin C, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk C J Neurooncol. 2005; 72(2):115-22.

PMID: 15925990 DOI: 10.1007/s11060-004-2061-z.